Catalyst Wire Dossier Catalyst Wire Dossier

RPL554

RPL554 · Verona Pharma plc
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for RPL554, covering 2015-10-28 to 2022-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing